Novo Nordisk's shares rose by 4.5% on average after the announcement of an improvement in net profit compared to expectations.
This pharmaceutical company from Denmark reported financial results that radically exceeded the analysts' and investors' expectations. Novo Nordisk's net profit for the last quarter was higher than forecasts, which triggered a rise in the value of its shares.
"We are very pleased with how the year has ended for our company. We had an excellent last quarter, our net profit exceeded all expectations," noted a representative of Novo Nordisk in a press interview.
Overall, this financial report allowed Novo Nordisk's shares to rise by 4.5%, recovering after some setbacks in the market.
